Ropivacaine Hydrochloride Hydrate

盐酸罗哌卡因

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameRopivacaine Hydrochloride Hydrate
Drug Alias Nameropivacainum罗哌卡因Anapeine耐乐品Naropin +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsRejection of renal transplantationStress Disorders, Post-TraumaticPersonal Satisfaction +[33] 
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritorySweden
Original Approved Date1995/09/15
Country/TerritoryCanadaUnited StatesSweden +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoTLC Biopharmaceuticals IncPatel Hospital +[15] 
Inactive CompaniesBioq Pharma IncMaastricht University Medical CenterSpectrum Health Corp +[32] 
Active IndicationsStress Disorders, Post-TraumaticRotator Cuff InjuriesRenal Colic +[11] 
Inactive IndicationsRejection of renal transplantationPersonal SatisfactionRib Fractures +[22] 

Other Information

ATC CodeN01BB09
Related LinksWikipediaDrugBankKEGG